Through the support of renowned alum Leon Lachman, the Institute harnesses expertise and enhances collaboration to move pharmaceutical therapies from the lab into the clinic....
A new clinical trial led by researchers at the University of Wisconsin-Madison could increase access to eye screenings for patients in rural Wisconsin....
In a little over 18 months, UW-Madison has conducted COVID vaccine and treatment trials in all age groups (ages 7 months- 96 years old). These trials are a representation of all people (race, religion, sex) in Wisconsin- nearly 700 participants....
More patients in rural areas across the nation could soon have increased access to vision-saving eye screenings based on a new multi-center clinical trial, led by an investigator at the University of Wisconsin Department of Ophthalmology and Visual Sciences....
Betsy Nugent and Nasia Safdar are working together to advance the clinical trials enterprise at the UW School of Medicine and Public Health and UW Health, while building the new Wisconsin Medicine Institute for Clinical Trials....
University of Wisconsin–Madison researchers and their collaborators are making progress toward developing universal vaccines against some the planet’s most harmful pathogens, including the virus family responsible for the COVID-19 pandemic....
hough it might be easy to picture a scene out of “Jaws,” these sharks have arrived to help humans, not hunt them. In fact, the sharks will be integral to research focused on therapies for diseases such as cancer. ...
While electronic medical records clearly have a long list of benefits—they’re legible, portable, shareable and can contain real-time alerts for physicians—the field is still growing and evolving, and some challenges have emerged along the way....
Thanks to leadership from Nasia Safdar, MD, PhD, professor, Infectious Disease, and colleagues, the William S. Middleton Memorial Veterans Hospital will join a national network of VA medical centers dedicated to strengthening clinical research at those centers....
Small, unique antibody-like proteins known as VNARs — derived from the immune systems of sharks — can prevent the virus that causes COVID-19, its variants, and related coronaviruses from infecting human cells, according to a new study....
